References 
[1] Stern, B. J. 2004. Neurological complications of sarcoidosis. Curr Opin Neurol, 17, 311–6.
Burns, T. M. 2003. Neurosarcoidosis. Arch Neurol, 60, 1166–8.
[2] Bradshaw MJ, Pawate S, Koth LL, Cho TA, Gelfand JM. Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 4;8(6):e1084.
[3] Herring AB, Urich H. Sarcoidosis of the central nervous system. J Neurol Sci. 1969 Nov-Dec;9(3):405-22.
[4] 2018 Neurosarcoidosis Consortium Consensus.JAMA Neurol. 2018;75(12):1546-1553.
[5] Hutto SK, Kyle K, Balaban DT, Martinez-Lage M, Venna N. Ischemic stroke in neurosarcoidosis: A retrospective cohort analysis. Mult Scler Relat Disord. 2022 Dec;68:104227
[6] Bathla G, Watal P, Gupta S, Nagpal P, Mohan S, Moritani T. Cerebrovascular Manifestations of Neurosarcoidosis: An Underrecognized Aspect of the Imaging Spectrum. AJNR Am J Neuroradiol. 2018 Jul;39(7):1194-1200. doi: 10.3174/ajnr.A5492. Epub 2017 Dec 28.
[7] Olugemo OA, Stern BJ. STROKE AND NEUROSARCOIDOSIS. In: Caplan LR, Bogousslavsky J, eds. Uncommon Causes of Stroke . Cambridge University Press; 2008:75-80.
[8] Raza N, Schreck KC. Neurosarcoidosis presenting with recurrent strokes: a case report and literature review. Neurohospitalist 2017;7: 91–95
[9] ROBERT F. Sarcoidosis of the central nervous system. Report of a case and review of the literature. Arch Neurol. 1962 Nov;7:442-9.
[10]Jachiet, V., Lhote, R., Rufat, P., et al., 2018. Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis. J. Neurol. 265, 2333–2341. Kidd, D.P., 2018.
[11]Meyer, J.S., Foley, J.M., Campagna-pinto, D., 1953. Granulomatous angiitis of the meninges in sarcoidosis. AMA Arch. Neurol. Psychiatry 69, 587–600
[12] Ko JK, Lee SW, Choi CH. Moyamoya-like vasculopathy in neurosarcoidosis. J Korean Neurosurg Soc 2009;45:50–52
[13] Minomo S, Ichijo M, Sato Y, Miyazaki R, Amino T, Kamata T. Cardioembolic Stroke Due to Cardiac Sarcoidosis Diagnosed by Pathological Evaluation of the Retrieved Thrombus. Intern Med. 2022 May 15;61(10):1599-1602.
[14] Benavente OR , Hart RG , et al. , SPS3 Investigators . Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367 :817–25.
[15] Amarenco P , Benavente O , Goldstein LB , et al  . Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes. Stroke 2009;40 :1405–9.
[16]Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016;16(1):220
[17] Rezaee M, Zangiabadian M, Soheili A, Calcagno TM, Rahmannia M, Dinparastisaleh R, Nasiri MJ, Mirsaeidi M. Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: A meta-analysis. Eur J Intern Med. 2023 Mar;109:42-49. doi:10.1016/j.ejim.2022.12.003. Epub 2022 Dec 14.
[18] Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467.